lactic acid has been researched along with insulin glargine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeYoung, MB; Herbert, P; MacConell, L; Sarin, V; Trautmann, M | 1 |
| Blancho, G; Branchereau, J; Cantarovich, D; Gauttier, V; Hervouet, J; Karam, G; Kervella, D; Le Bas-Bernardet, S; Mesnard, B; Minault, D; Ogbemudia, AE; Prudhomme, T; Renaudin, K | 1 |
1 review(s) available for lactic acid and insulin glargine
| Article | Year |
|---|---|
Encapsulation of exenatide in poly-(D,L-lactide-co-glycolide) microspheres produced an investigational long-acting once-weekly formulation for type 2 diabetes.
Topics: Adult; Blood Glucose; Capsules; Diabetes Mellitus, Type 2; Exenatide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Injections, Subcutaneous; Insulin Glargine; Insulin, Long-Acting; Lactic Acid; Peptides; Pioglitazone; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Pyrazines; Sitagliptin Phosphate; Thiazolidinediones; Triazoles; Venoms | 2011 |
1 other study(ies) available for lactic acid and insulin glargine
| Article | Year |
|---|---|
Total Pancreatectomy and Pancreatic Allotransplant in a Porcine Experimental Model.
Topics: Animals; Biomarkers; Blood Glucose; Blood Platelets; C-Peptide; Diabetes Mellitus, Type 1; Disease Models, Animal; Feasibility Studies; Hypoglycemic Agents; Insulin Glargine; Lactic Acid; Male; Pancreas Transplantation; Pancreatectomy; Sus scrofa; Time Factors; Transplantation, Homologous | 2020 |